Myocardium-specific Tomoregulin-1 knockdown (referred to as knockdown) and myocardium-specific Tomoregulin-1 overexpression mice (referred to as overexpression) as well as non-transgenic (NTG) littermates at 8 to 10 weeks of age were used for thoracic aorta constriction (TAC) operation. Briefly, mice were anesthetized by intraperitoneal injection 18ml/kg body weight tribromoethanol. The surgery was performed under passive respiration using a ventilator (125~150 times/min). The aorta was constricted between the origin of the right innominate and left common carotid arteries with a 6/0 polypropylene ligature using a blunted 27-gauge (0.41-mm OD) needle as a calibrator. The sham procedure was identical except that the aorta was not ligated. All the surviving mice were chosen for follow-up M-mode echocardiography at 4 weeks after surgery. The data were shown in the followed Supplemental 
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Disease Models & Mechanisms 8: doi:10.1242/dmm.021303: Supplementary Material To verify whether the Tomoregulin-1 overexpression could affect the cardiac geometry and function in thoracic aorta constriction (TAC)-induced cardiac hypertrophy myocardium for long time, M-mode echocardiography was performed at 16 weeks after TAC operation on Tomoregulin-1 overexpression mice (referred to as overexpression) as well as non-transgenic (NTG) littermates. The data were shown in the followed Supplemental Table S7 . 
Supplemental Figures
To verify whether the Tomoregulin-1 could affect the cardiac geometry and function, we generated two lines of myocardium-specific Tomoregulin-1 knockdown mice (founder 24 and 31) and Tomoregulin-1 overexpression mice (founder 2 and 3). of age were showed in Figure S1 . 
